BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26580855)

  • 1. Serological markers of hepatitis B and C in patients with HIV/AIDS and active tuberculosis.
    Araújo-Mariz C; Lopes EP; Ximenes RA; Lacerda HR; Miranda-Filho DB; Montarroyos UR; Barreto S; Salustiano DM; Albuquerque MF
    J Med Virol; 2016 Jun; 88(6):996-1002. PubMed ID: 26580855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goiânia City, Brazil.
    Aires RS; Matos MA; Lopes CL; Teles SA; Kozlowski AG; Silva AM; Filho JA; Lago BV; Mello FC; Martins RM
    J Clin Virol; 2012 Aug; 54(4):327-31. PubMed ID: 22608842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus.
    Drosten C; Nippraschk T; Manegold C; Meisel H; Brixner V; Roth WK; Apedjinou A; Günther S
    J Clin Virol; 2004 Jan; 29(1):59-68. PubMed ID: 14675872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
    Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
    Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianópolis--Brazil.
    Treitinger A; Spada C; Ferreira LA; Neto MS; Reis M; Verdi JC; de Miranda AF; de Oliveira OV; Van der Sander Silveira M; Abdalla DS
    Braz J Infect Dis; 2000 Aug; 4(4):192-6. PubMed ID: 11008223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of hepatitis B and C among tuberculosis patients in Duhok Province, Kurdistan: Are HBsAg and anti-HCV prerequisite screening parameters in tuberculosis control program?
    Merza MA; Haji SM; Alsharafani AM; Muhammed SU
    Int J Mycobacteriol; 2016 Sep; 5(3):313-317. PubMed ID: 27847016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
    Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
    Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
    Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
    J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
    Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
    J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Rates of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus Infections and Uncommon HBV Genotype/Subtype and HCV Subtype Distributions among Transgender Individuals in Surabaya, Indonesia.
    Hadikusumo AA; Utsumi T; Amin M; Khairunisa SQ; Istimagfirah A; Wahyuni RM; Lusida MI; Soetjipto ; Rianto E; Juniastuti ; Hayashi Y
    Jpn J Infect Dis; 2016 Nov; 69(6):493-499. PubMed ID: 27000450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral hepatitis prevalence in patients with active and latent tuberculosis.
    Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA
    World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals.
    Flores GL; de Almeida AJ; Miguel JC; Cruz HM; Portilho MM; Scalioni Lde P; Marques VA; Lewis-Ximenez LL; Lampe E; Villar LM
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26978383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus.
    Mo P; Zhu Q; Teter C; Yang R; Deng L; Yan Y; Chen J; Zeng J; Gui XE
    Int J Infect Dis; 2014 Nov; 28():95-100. PubMed ID: 25218771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
    Al-Mughales JA
    J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
    Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
    Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection.
    Liang SH; Chen TJ; Lee SS; Tseng FC; Huang CK; Lai CH; Chiou CP; Wang JL; Chung HC; Lin JN; Kuo YC; Lin HH
    J Acquir Immune Defic Syndr; 2010 Jun; 54(2):122-8. PubMed ID: 20386111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.